These results establish strong foundations for further investigation of PF-04691502, highlighting the effectiveness of this molecule for CNS disorders, also emphasizing the modulation of PI3K/mTOR signaling as a feasible healing approach. This evidence concerns the gene MTOR and central nervous system disorder.